Almac Clinical Technologies

Almac Clinical Technologies is listed in the EU-US Data Privacy Framework (DPF) registry as active, covering EU-US, UK Extension, and Swiss-US certifications, as of 12 Oct 2026. The DPF registry shows an original issue date of 24 Jul 2017 and an expiration date of 29 Jul 2027, as of 12 Oct 2026. This DPF listing is the only framework evidence supplied for Almac Clinical Technologies as of 12 Oct 2026. No public evidence was found for SOC 2, HIPAA, or PCI DSS for Almac Clinical Technologies as of 12 Oct 2026. Based on the registry record, the DPF certification for Almac Clinical Technologies remains active through the stated 2027 expiry, as of 12 Oct 2026.

• EU-US DPF: listed in DPF registry as active (EU-US, UK Extension, SW-US), issued 24 Jul 2017, expires 29 Jul 2027, as of 12 Oct 2026.
• SOC 2: no public evidence found as of 12 Oct 2026.
• HIPAA: no public evidence found as of 12 Oct 2026.

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 15 Oct 2026; it is regenerated whenever a row changes.